Leonard S. Schleifer
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2023-06-09
- Valid until
- still holds
- Published
- 2023-04-17
- Recorded by AsOf
- 2026-11-12
- Checked
- 2026-11-12 · its source page states the value and the date
- Confidence
- 0.95
Sources
“Effective upon the expiration of Dr. Vagelos’s term, the Board plans to elect Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of the Company, and George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of the Company, as Co-Chairs of the Board”— what the page says, read 2026-11-12
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals chair: Leonard S. Schleifer", as of 2023-06-09. Claim clm_E84D1B159AB1, https://asof.is/claim/clm_E84D1B159AB1, accessed 2026-11-12. Source: https://www.sec.gov/Archives/edgar/data/872589/000110465923045897/0001104659-23-045897-index.htm.
APA
AsOf. (2023). Regeneron Pharmaceuticals chair: Leonard S. Schleifer (as of 2023-06-09) [Record clm_E84D1B159AB1]. Retrieved November 12, 2026, from https://asof.is/claim/clm_E84D1B159AB1 (source: https://www.sec.gov/Archives/edgar/data/872589/000110465923045897/0001104659-23-045897-index.htm)
BibTeX
@misc{asof_clm_E84D1B159AB1,
author = {AsOf},
title = {Regeneron Pharmaceuticals chair: Leonard S. Schleifer},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_E84D1B159AB1}},
note = {Claim clm\_E84D1B159AB1, as of 2023-06-09; source: https://www.sec.gov/Archives/edgar/data/872589/000110465923045897/0001104659-23-045897-index.htm},
urldate = {2026-11-12}
}On the record
/claim/clm_E84D1B159AB1.md/v1/claims/clm_E84D1B159AB1submit a correction